Nutex Health raises price target to $280 amid Nasdaq listing
NUTEXNUTX
Statements (2)
- Neutral
Nutex Health is near a Texas listing on the Nasdaq, potentially creating a 29% undervaluation.
- Bullish
Nutex Health is raising its price target for the stock to $280